PHARMING GROUP

Pharming Group specializes in the development of innovative products for the treatment of genetic disorders, specialty products for surgical indications, and nutritional products. The group's technologies include innovative platforms for the production of protein therapeutics, technology and processes for the purification and formulation of these products, as well as technology in the field of DNA repair (DNAge). Net sales break down by type of revenues into grants (69.4%) and licence fees (30.6%).